Virtus Biotech ETF
15 hedge funds and large institutions have $4.29M invested in Virtus Biotech ETF in 2015 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 2 closing their positions.
40% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 5
31% more capital invested
Capital invested by funds: $3.28M → $4.29M (+$1.01M)
6% less funds holding
Funds holding: 16 → 15 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$806K |
| 2 |
LPL Financial
San Diego,
California
|
+$806K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$158K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$82.4K |
| 5 |
AIG
American International Group
New York
|
+$16.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$635K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$425K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$23.5K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$6.61K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
-$6.06K |
BBP Hedge Fund Activity: Q4 2015 in Review
15 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Virtus Biotech ETF (BBP) for Q4 2015, worth a combined $4.29M — up 31% from $3.28M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of BBP and 1 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 7 added.
The largest buyer was Jane Street, adding an estimated $806K. The largest seller was Credit Suisse, exiting entirely with an estimated $635K sold.
- 15 institutional investors held Virtus Biotech ETF (BBP) as of Q4 2015, down from 16 in Q3 2015.
- Funds reported $4.29M of Virtus Biotech ETF stock for Q4 2015, up 31% quarter-over-quarter.
- 1 fund opened new Virtus Biotech ETF positions in Q4 2015 and 2 closed out, a net change of -1 holder.
- The largest Virtus Biotech ETF buyer in Q4 2015 was Jane Street, an estimated $806K added.
- The largest Virtus Biotech ETF seller in Q4 2015 was Credit Suisse, an estimated $635K sold.
Based on aggregated 13F filings for Q4 2015.